FHL2 Antikörper (C-Term)
Kurzübersicht für FHL2 Antikörper (C-Term) (ABIN185198)
Target
Alle FHL2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- FHL2
-
Sequenz
- RDDILCPDCG KDI
-
Spezifität
- Reported variants represent identical protein (NP_001441.4, NP_963849.1, NP_963851.2, NP_001034581.1).
-
Kreuzreaktivität
- Rind (Kuh), Hund, Human, Maus, Ratte
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence RDDILCPDCGKDI, from the C Terminus of the protein sequence according to NP_001441.4.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: Approx 30 kDa band observed in Human and Mouse Heart lysates (calculated MW of 32.2 kDa according to NP_001441.4). Recommended concentration: 1-3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:16000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- FHL2 (Four and A Half LIM Domains 2 (FHL2))
-
Andere Bezeichnung
- FHL2
-
Hintergrund
- FHL2, DRAL, AAG11, SLIM3, four and a half LIM domains 2, down-regulated in rhabdomyosarcoma LIM protein, aging-associated gene 11, four and a half LIM-domain protein 2, OTTHUMP00000203164, OTTHUMP00000203168, OTTHUMP00000203169
-
Gen-ID
- 2274, 14200, 63839
-
NCBI Accession
- NP_001441
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Lipid Metabolism by PPARalpha
Target
-